Newspaper article from our research archive:

Study shows patient deaths have declined in early studies of new cancer drugs

CHICAGO -- Experiments in which new cancer drugs are tested on patients are not as risky as they were a decade ago, according to a study that found a sharp drop in deaths from 1991 to 2002.

At the same time, there was also a decline in the percentage of tumors that shrank in response to the drugs being tested. But the researchers and other cancer experts said that does not mean the drugs were increasingly ineffective.

Some of the newest cancer drugs employ a more targeted approach than older medicines, attacking tumor cells while causing less damage to healthy tissue.

These drugs often work by stopping but not necessarily reversing tumor growth, said Dr. Thomas Roberts Jr. of Massachusetts ...

Related newspaper, magazine, and journal articles:

See all results. Or, try our Advanced Search.

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 60 million articles! Access over 3,500 publications with a FREE trial!